S W Johnson

Author PubWeight™ 54.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 1999 2.20
2 Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. Biochem Pharmacol 2000 1.58
3 The biology of ovarian cancer. Semin Oncol 1998 1.46
4 Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br J Cancer 2005 1.42
5 Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol 2000 1.31
6 Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons. Neurosci Lett 1992 1.30
7 The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res 2000 1.27
8 Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group. J Clin Oncol 1996 1.21
9 GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci 2001 1.20
10 Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J Physiol 1997 1.11
11 Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res 1995 1.11
12 Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol Sci 1999 1.11
13 Measuring quality of care in psychiatric emergencies: construction and evaluation of a Bayesian index. Health Serv Res 1993 1.04
14 Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule. Cancer Res 1994 1.03
15 Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res 1993 1.01
16 Dopamine receptors set the pattern of activity generated in subthalamic neurons. FASEB J 2005 0.96
17 Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci 1995 0.94
18 Clinical pharmacokinetics and administration of established platinum drugs. Drugs 2000 0.94
19 Effects of anoxia on rat midbrain dopamine neurons. J Neurophysiol 1994 0.92
20 Influences of electrode geometry on bipolar recordings of the surface electromyogram. Med Biol Eng Comput 1978 0.92
21 Miniature skin-mounted preamplifier for measurement of surface electromyographic potentials. Med Biol Eng Comput 1977 0.92
22 Translocation and activation of AKT2 in response to stimulation by insulin. J Cell Biochem 1998 0.91
23 Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J Pharmacol Exp Ther 1995 0.90
24 Gene expression profiling of human ovarian tumours. Br J Cancer 2006 0.90
25 Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res 1994 0.87
26 Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J Pharmacol Exp Ther 1998 0.86
27 Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice. J Pharmacol Exp Ther 1996 0.86
28 Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons. Neuroscience 2007 0.84
29 Sulfonylurea-sensitive potassium current evoked by sodium-loading in rat midbrain dopamine neurons. Neuroscience 1996 0.83
30 Presynaptic inhibition of synaptic transmission by adenosine in rat subthalamic nucleus in vitro. Neuroscience 2003 0.82
31 Presynaptic GABA(B) receptors inhibit synaptic inputs to rat subthalamic neurons. Neuroscience 2001 0.82
32 Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience 1994 0.82
33 Potentiation of GABA(A) receptor agonists by GABA uptake inhibitors in the rat ventral midbrain. Eur J Pharmacol 2001 0.81
34 Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel. Clin Cancer Res 1996 0.81
35 Presynaptic dopaminergic activity of phencyclidine in rat caudate. J Pharmacol Exp Ther 1984 0.80
36 Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons. Neuroscience 2011 0.80
37 A slow excitatory postsynaptic current mediated by G-protein-coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. Eur J Neurosci 1997 0.80
38 Metabotropic glutamate and muscarinic cholinergic receptor-mediated preferential inhibition of N-methyl-D-aspartate component of transmissions in rat ventral tegmental area. Neuroscience 2003 0.80
39 Correlation of mutagenic and dermal carcinogenic activities of mineral oils with polycyclic aromatic compound content. Fundam Appl Toxicol 1988 0.80
40 Glycine receptor-mediated inhibition of dopamine and non-dopamine neurons of the rat ventral tegmental area in vitro. Brain Res 2001 0.79
41 Sodium pump evokes high density pump currents in rat midbrain dopamine neurons. J Physiol 1998 0.79
42 Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons. Br J Pharmacol 1999 0.79
43 The chemopreventive agent oltipraz stimulates repair of damaged DNA. Cancer Res 1997 0.79
44 Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin. Cancer Chemother Pharmacol 1996 0.78
45 Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology 1983 0.78
46 5-HT inhibits synaptic transmission in rat subthalamic nucleus neurons in vitro. Neuroscience 2007 0.78
47 Sulfonylureas enhance GABAA synaptic potentials in rat midbrain dopamine neurones. Acta Physiol Scand 1996 0.78
48 Dual modulation of gabaergic transmission by metabotropic glutamate receptors in rat ventral tegmental area. Neuroscience 2003 0.78
49 Nitric oxide facilitates N-methyl-D-aspartate-induced burst firing in dopamine neurons from rat midbrain slices. Neurosci Lett 1998 0.77
50 Growth regulation of ovarian cancer. Hematol Oncol Clin North Am 1992 0.77
51 Norepinephrine-dependent and independent mechanisms of persistent effects of amphetamine in rat cerebellum. Life Sci 1985 0.77
52 Correlation of Purkinje neuron depression and hypnotic effects of ethanol in inbred strains of rats. Alcohol Clin Exp Res 1985 0.76
53 Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers. Mol Pharmacol 1999 0.76
54 Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate. J Neurosci 1986 0.76
55 Hydrolysis of fucosyl-GM1 ganglioside by purified pellet-associated human brain and human liver alpha-L-fucosidases without activator proteins or detergents. Biochem J 1990 0.76
56 Analysis of the subunits, isoforms and substrate specificity of mouse liver alpha-L-fucosidase. Comp Biochem Physiol B 1993 0.76
57 Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochem Pharmacol 1999 0.76
58 DNA binding activity of the mammalian translation elongation complex: recognition of chromium- and transplatin-damaged DNA. Arch Toxicol 1997 0.75
59 Persistent effects of amphetamine on cerebellar Purkinje neurons following chronic administration. Brain Res 1982 0.75
60 The use of a stirring wheel in the study of patterns of arm and trunk movements in normal subjects and hemiplegic patients [proceedings]. J Physiol 1977 0.75
61 Quality assurance for psychiatric emergencies. An analysis of assessment and feedback methodologies. Psychiatr Clin North Am 1990 0.75
62 Identification of the stretch reflex using pseudorandom excitation: electromyographic response to displacement of the human forearm. Med Biol Eng Comput 1981 0.75
63 L-arginine potentiates GABA-mediated synaptic transmission by a nitric oxide-independent mechanism in rat dopamine neurons. Neuroscience 1997 0.75
64 Anticonvulsant effects of acute and chronic phenytoin treatment in Rana pipiens. Proc West Pharmacol Soc 1980 0.75
65 Mutual expectations. How family members view the social role of the mental health center client. J Psychosoc Nurs Ment Health Serv 1986 0.75
66 Leisure: how to promote inpatient motivation after discharge. J Psychosoc Nurs Ment Health Serv 1989 0.75
67 Effects of d-amphetamine withdrawal in rats and man. Am J Psychiatry 1983 0.75
68 Dose-response analysis of phenytoin on electrically induced seizures and spontaneous activity of cerebellar purkinje cells in the frog. Epilepsia 1982 0.75
69 Client counseling in orthopedic emergencies. Vet Clin North Am Small Anim Pract 1995 0.75
70 Prolonged exposure to mine tailings and survival and reproductive success of ovigerous tanner crabs (Chionoecetes bairdi). Bull Environ Contam Toxicol 1998 0.75
71 Structure-activity relationships of phencyclidine derivatives in rat cerebellum. Pharmacol Biochem Behav 1986 0.75
72 Phenytoin antagonism of electrically induced maximal seizures in frogs and mice and effects on central nervous system levels of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. J Pharmacol Exp Ther 1982 0.75
73 A comparative study of the effects of phenytoin and phenobarbital on electrically induced maximal seizures in frogs and mice. J Pharmacol Exp Ther 1982 0.75
74 Molecular biology of gynecologic malignancies. Cancer Treat Res 1998 0.75
75 Survival, growth, and bioaccumulation of heavy metals by juvenile Tanner crabs (Chionoecetes bairdi) held on weathered mine tailings. Bull Environ Contam Toxicol 1997 0.75
76 Reflex electromyographic response to random limb displacement [preceedings]. J Physiol 1979 0.75
77 Acquisition and analysis of electromyographic data associated with dynamic movements of the arm. Med Biol Eng Comput 1980 0.75
78 Metabolism, tissue distribution, and elimination kinetics of phenytoin in the frog. Drug Metab Dispos 1983 0.75
79 A skin-mounted preamplifier for recording the surface electromyogram (e.m.g.) [proceedings]. J Physiol 1977 0.75
80 Recent insights into drug resistance in ovarian cancer. Methods Mol Med 2001 0.75
81 Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cells. Gynecol Oncol 1995 0.75
82 Ability of periaqueductal gray subdivisions and adjacent loci to elicit analgesia and ability of naloxone to reverse analgesia. Behav Neurosci 1989 0.75
83 Apollo 12 lunar module impact: laboratory simulation and possible downrange ballistic effects. Science 1970 0.75
84 The solubility of phenytoin in a physiological salt solution. Methods Find Exp Clin Pharmacol 1980 0.75
85 Antagonism of metrazol-induced convulsions by sodium bromide in Rana pipiens. Proc West Pharmacol Soc 1977 0.75
86 Role of the medical oncology social worker. Ariz Med 1977 0.75